Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $20,627 - $26,264
-187 Reduced 3.86%
4,663 $528,000
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $27,983 - $34,324
245 Added 5.32%
4,850 $672,000
Q4 2023

Feb 06, 2024

BUY
$75.49 - $124.16 $11,625 - $19,120
154 Added 3.46%
4,605 $571,000
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $2,753 - $4,413
32 Added 0.72%
4,451 $415,000
Q2 2023

Aug 09, 2023

BUY
$112.47 - $130.98 $84,689 - $98,627
753 Added 20.54%
4,419 $567,000
Q1 2023

May 04, 2023

BUY
$104.0 - $122.92 $17,472 - $20,650
168 Added 4.8%
3,666 $425,000
Q4 2022

Feb 03, 2023

SELL
$84.98 - $122.67 $15,381 - $22,203
-181 Reduced 4.92%
3,498 $396,000
Q3 2022

Nov 02, 2022

SELL
$76.35 - $94.18 $15,728 - $19,401
-206 Reduced 5.3%
3,679 $296,000
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $192,343 - $375,945
2,829 Added 267.9%
3,885 $290,000
Q1 2022

Apr 19, 2022

BUY
$94.08 - $130.2 $56,448 - $78,120
600 Added 131.58%
1,056 $540,000
Q4 2021

Jan 24, 2022

BUY
$129.87 - $162.82 $57,402 - $71,966
442 Added 3157.14%
456 $245,000
Q3 2021

Oct 19, 2021

SELL
$106.71 - $143.18 $1,280 - $1,718
-12 Reduced 46.15%
14 $8,000
Q2 2021

Jul 13, 2021

SELL
$80.99 - $107.93 $6,398 - $8,526
-79 Reduced 75.24%
26 $11,000
Q4 2020

Feb 04, 2021

SELL
$78.0 - $104.5 $1,638 - $2,194
-21 Reduced 16.67%
105 $39,000
Q3 2020

Oct 26, 2020

BUY
$95.51 - $112.95 $191 - $225
2 Added 1.61%
126 $52,000
Q2 2020

Jul 06, 2020

BUY
$62.68 - $105.34 $62 - $105
1 Added 0.81%
124 $50,000
Q4 2019

Feb 05, 2020

BUY
$36.62 - $57.29 $4,247 - $6,645
116 Added 1657.14%
123 $27,000
Q3 2019

Oct 08, 2019

BUY
$35.53 - $43.8 $71 - $87
2 Added 40.0%
7 $1,000
Q2 2019

Aug 20, 2019

SELL
$27.84 - $38.92 $111 - $155
-4 Reduced 44.44%
5 $1,000
Q4 2018

Jan 25, 2019

BUY
$26.99 - $37.37 $242 - $336
9 New
9 $1,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.